Sofinnova Investments related stories
All articles and analysis
Cebix Incorporated Inks $30.9m Series C and Appoints President and CEOCebix Incorporated, a biopharmaceutical company developing treatments for complications of diabetes, has secured a $30.9M Series B investment. Prior investors InterWest, Sofinnova Ventures and Thomas, McNerney & Partners all participated in the financing. The company has also appointed Dr. Joel Martin as president and CEO.
Fund Performance: Top Funds Outpace the Losers in OPERSTop three funds expanding their gap among the rest in Oregon Public Employees Retirement System’s venture portfolio
- peHUB First Read
Everyone, please meet Radish the cat, peHUB's new intern. We're still training her to fetch coffee. Or, anything.
- Mid-Life Venture Funds Break Into the Black: A Look at UTIMCO’s Mid-Decade Portfolio: Slideshow
Venture fund performance began to recover from the excesses of the bubble years in 2003 and 2004 before dipping again in the following two years of 2005 and 2006. There are signs these now mid-life funds with ’05 and ’06 vintages are starting to hit a better stride.
- European LP News, May 2012
LPs are seeking more co-investments with their PE, according to Preqin; and other LP-related briefs
- UTIMCO Bets On Early Stage Technology Funds With Its Latest Batch Of Venture Investments
The endowment committed $337.5 million to 11 funds in 2010 and 2011, according to its November portfolio report. Nine focus on technology or allocate some portion of their funds to tech. Two zero in on health care.
- UTIMCO Takes A Big Piece Of Ehrenberg’s New Fund, Adds Union Square, True Ventures And Artiman Funds: Slideshow
The University of Texas Management Company is among the largest investors in Roger Ehrenberg’s second fund, with a 30% stake of his new IA Ventures Strategies Fund II, according to a recent UTIMCO portfolio report.